Cartesian Therapeutics (RNAC) EBT Margin (2015 - 2026)
Cartesian Therapeutics' EBT Margin came in at -32657.69% for Q1 2026, down 30850.97 percentage points from -1806.73% a year earlier and down 24487.58 percentage points from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) EBT Margin (2015 - 2026) Analysis & Trends
For FY2025, Cartesian Therapeutics' EBT Margin was -4987.31%, down 4789.08 percentage points from FY2024.
- EBT Margin carries a five-year change of -4572.32 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -198.23% in FY2024 (+719.74 pp), -917.97% in FY2023 (-949.36 pp), 31.39% in FY2022 (+42.81 pp) and -11.43% in FY2021 (+403.56 pp).
- The Q1 2026 figure represents the lowest quarterly EBT Margin since Q2 2019.
- Year-over-year, EBT Margin increased in 1 of the last six quarters, with an average year-over-year change of -7169.92 percentage points.
- The fastest year-over-year change in EBT Margin over five years came in Q2 2024 (a gain of 387.55 percentage points), and the weakest in Q1 2026 (a drop of 30850.97 percentage points).
- Business Quant data shows RNAC's EBT Margin at -8170.12% (Q4 2025), -4318.14% (Q3 2025) and -6732.55% (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -4.34% |
| 10 | Cartesian Therapeutics | 188.59 Mn | -346.18 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -32,657.69% |
| Dec 31, 2025 | -8,170.12% |
| Sep 30, 2025 | -4,318.14% |
| Jun 30, 2025 | -6,732.55% |
| Mar 31, 2025 | -1,806.73% |
| Sep 30, 2024 | -3,876.49% |
| Jun 30, 2024 | 44.71% |
| Mar 31, 2024 | -208.63% |
| Dec 31, 2023 | -2,379.12% |
| Sep 30, 2023 | -137.41% |
| Jun 30, 2023 | -342.85% |
| Mar 31, 2023 | -300.74% |
| Dec 31, 2022 | 33.37% |
| Sep 30, 2022 | -39.66% |
| Jun 30, 2022 | 34.00% |
| Mar 31, 2022 | 29.65% |
| Dec 31, 2021 | 41.34% |
| Sep 30, 2021 | -8.46% |
| Jun 30, 2021 | -1.26% |
| Mar 31, 2021 | -71.10% |
API Access
Cartesian Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();